Many Thanks to All Brown, Melissa M.; Brown, Gary C.; Kertes, Peter; More Brown, Melissa M.; Brown, Gary C.; Kertes, Peter; Stein, Joshua Less Evidence-Based Ophthalmology. 12(4):168, October 2011. Favorites PDF Get Content & Permissions
What We're All About Less Evidence-Based Ophthalmology. 12(4):169-170, October 2011. Favorites PDF Get Content & Permissions
MEASURING THE SIZE OF A TREATMENT EFFECT: RELATIVE RISK REDUCTION, ABSOLUTE RISK REDUCTION, AND NUMBER NEEDED TO TREAT Hollands, Hussein; Kertes, Peter J. Hollands, Hussein; Kertes, Peter J. Less Evidence-Based Ophthalmology. 12(4):171-175, October 2011. Favorites PDF Get Content & Permissions
Levels Of Evidence Sharma, Sanjay Sharma, Sanjay Less Evidence-Based Ophthalmology. 12(4):176-177, October 2011. Favorites PDF Get Content & Permissions
EFFICACY OF INTRAVITREAL BEVACIZUMAB FOR STAGE 3+ RETINOPATHY OF PREMATURITY Tasman, William Tasman, William Less Evidence-Based Ophthalmology. 12(4):178-179, October 2011. Favorites PDF Get Content & Permissions
GENERAL HEALTH-RELATED QUALITY OF LIFE IN PRESCHOOL CHILDREN WITH STRABISMUS OR AMBLYOPIA Carlton, Jill Carlton, Jill Less Evidence-Based Ophthalmology. 12(4):212-213, October 2011. Favorites PDF Get Content & Permissions
COST-UTILITY ANALYSIS: THE FOUNDATION OF VALUE-BASED MEDICINE GUIDELINES TO MASTER WHEN PERFORMING OR EVALUATING A COST-UTILITY ANALYSIS Brown, Gary C.; Brown, Melissa M.; Kertes, Peter; More Brown, Gary C.; Brown, Melissa M.; Kertes, Peter; Stein, Joshua Less Evidence-Based Ophthalmology. 12(4):218-223, October 2011. Favorites PDF Get Content & Permissions
